Mr Matthew Liew

Mr Matthew Liew is a Consultant Urological Surgeon based in Warrington and Manchester, practising privately at Spire Cheshire and Spire Manchester Hospitals and within the NHS at Liverpool University Hospital Foundation Trust. His sub-specialty interests include benign prostate surgery, kidney, ureteric and bladder stone disease, bladder cancer, and prostate cancer diagnostics. He is the Deputy Clinical Director for Innovation in Liverpool University Hospitals.

Mr Liew established the Greater Manchester NHS Holmium Laser Enucleation of the Prostate (HoLEP) service in 2017, and launched the first North West private HoLEP service at Spire Manchester in 2024. He is the highest volume HoLEP surgeon in the North West. He is recognised as a Key Opinion Leader in Endourology, and has worked with industry partners including Richard Wolf, Teleflex, and Coloplast. He has also been an invited speaker on HoLEP and chaired sessions for the British Association of Urological Surgeons (BAUS).

He graduated from Bart’s and The Royal London Hospital with MBBS and BMedSci (Hons, First Class) degrees, and was awarded a Doctor of Medicine (MD) by the University of Manchester for his research on kidney cancer chemotherapy resistance at the Christie Hospital.

An active researcher, Mr Liew has published over 30 peer-reviewed papers, served as Chief and Principal Investigator in international clinical trials, and contributed to National Bladder Cancer GIRFT guidelines, and European Urology Prostate Cancer guidelines.